Stephanie Graff, MD, FACP, FASCO
@DrSGraff
Followers
21K
Following
25K
Media
2K
Statuses
15K
Director Breast Oncology, Brown University Health | Assoc Prof Legorreta Cancer Center Brown Univ | Views Mine | https://t.co/WVUQaIHeKn | COI ⬇
Barrington, RI
Joined March 2017
Thanks @ASCO for asking me to share a #DayInTheLife as breast oncologist, researcher, leader, educator, mom. Here we capture a large piece. Other days are packed w/patient care (✨the best), and then there’a a mix of like this. I ❤️ my #oncology life. It’s the best job!
Follow along with breast oncologist & ASCO member @DrSGraff as she takes you through a #DayInTheLife, juggling cancer research, lectures & collaborations, family time, and more! On other days, her time is spent in clinic caring for patients with breast cancer.
11
17
127
Coming in at the finish line, I just logged my donation for #DiagnoseAndTreats #HCWvsHunger Who else needs to get their hat (? Or is it plate 🍽️) in the ring?
⏰It's the FINAL COUNTDOWN!! ⏰ #HCWvsHunger ends 12am ET tonight! Thanks to all who have donated to fight hunger for our #OncTwitter team #DiagnoseAndTreats! Plz share: We have a challenge grant that's doubles your impact INCLUDING the match. 🙏 https://t.co/zDjbnCwGVM
2
1
9
#HCWvsHunger 2025!!! #MedTwitter, join healthcare workers & others to #FightHunger! 🍎Donate to ANY foodbank or org fighting hunger. Screenshot receipt. 🍎Log it for your team of choice Th 11/27 6p - Tu 12/2 11:59p ET https://t.co/Lm4buiXLTW FAQs @
hcwvshunger.org
How to Contribute Donate between 6 pm EST on November 27 and 11:59 pm EST December 2, 2025 to an organization of your choice fighting hunger– any amount helps! Feeding America can help you cho…
1
14
21
1 week, friends. ⏳ Can’t wait to see you @SABCSSanAntonio #SABCS25
We are pleased to introduce the first group of Social Media Ambassadors for the San Antonio Breast Cancer Symposium. Follow them for their perspectives on the latest developments and join the conversation by sharing the exciting science being discussed with #SABCS25.
1
4
35
#SABCS25 is less than 2 weeks away! Honored to be @SABCSSanAntonio “Social Media Ambassador” representing general medical oncologists and our community colleagues. To stay updated on the latest from #SABCS follow along these thoughtful voices 👇👇 #OncTwitter #MedTwitter #MedEd
We are pleased to introduce the first group of Social Media Ambassadors for the San Antonio Breast Cancer Symposium. Follow them for their perspectives on the latest developments and join the conversation by sharing the exciting science being discussed with #SABCS25.
0
11
30
6 wks to go! Excited to discuss how the data from #SABCS25 will change/reinforce our practice at the Advancements in Oncology! In Person, 📆 Date: Dec 10, 2025 ⏰ Time: 7-9PM ✅ Register here: https://t.co/Zj8usjTg1o Her2: @sdent_cardioonc & @DrSGraff TNBC: @ErikaHamilton9
1
23
50
Translational data shows that #breastfeeding helps personal immunity improving CD8+ T This work can help to understand better the immune system and breastfeeding mechanisms @LoiSher @OncoAlert #ESMO25 @FernandoOnco
0
2
11
PROs from PATINA trial by @inesvazluis At #ESMO25 Adding palbociclib to HER2 therapy + ET in HR+/HER2+ MBC maintained HRQoL, with similar time to symptom progression (HR 0.89) & stable FACT-B TOI (66 vs 67 at 1 yr; 64 vs 67 at 3 yr) and EQ-5D-5L scores over time @OncoAlert
0
7
16
At #ESMO25 @Lucarecco from @JulesBordet presents results from the Brainstorm study CSF ctDNA in pts with brain and LM metastases had high mutational profile concordance with plasma and only partial overlap with extra-CNS tissue, while also uncovering CNS-specific mut @OncoAlert
1
19
45
SONIA overall survival analysis = no significant difference 1L vs 2L CDK4/6i, except premenopausal; draws same criticisms RE: low OS compared to historical trial, non-standard of care single agents & CDK4/6. Still impressive data adding value. #ESMO25 @OncoAlert
1
11
33
ASCENT-04 show sustained physical function and predictable side effects (diarrhea, nausea), reduced pain with Sacituzumab —@E_de_Azambuja #ESMO25 @OncoAlert
1
14
33
Final tally! 🗳️ #ESMO25 @OncoAlert
How are we feeling on Sunday morning RE: Destiny Breast 11 (neoadj) and DB-05 (residual disease)? What are we doing in the overlapping population? (Don’t vote just to see; that’s what the bookmark tab is for!) #ESMO25
0
8
16
Final hour to vote—with about an hour left and ~100 votes, TDXd for residual disease alone is in the lead…
How are we feeling on Sunday morning RE: Destiny Breast 11 (neoadj) and DB-05 (residual disease)? What are we doing in the overlapping population? (Don’t vote just to see; that’s what the bookmark tab is for!) #ESMO25
0
1
6
No time to wrap our head around two practice-changing trials (DB-09, PATINA), that a third innovation joins the frontline setting for HER2+ mBC. HER2CLIMB-05 is positive: tucatinib added to HP maintenance improves PFS. Could it prevent/delay brain mets? 🧠 https://t.co/CNgx8OKMRs
2
33
104
Dear Colleaguest at #ESMO25 A warm invite to our Flagship Event: REGISTER👉 https://t.co/qUgbE51xdK OncoAlert, ESGO, ESSO, MASCC, SIOG, and our esteemed faculty invite you to the 2026 #OncoAlertColloquium! Experience the very best in oncology delivered over 7 days, with each
0
10
14
Very interesting preliminary data to support the use of oral #SERD (in this case #giredestrant) without ovarian function suppression in premenopausal women with HR+/HER2- early #BreastCancer
@OncoAlert @myESMO #ESMO25 @AnnPartridgeMD
2
26
58
Absolutely terrific discussion by Dr. Ana Garrido-Castro @DFCI_BreastOnc of ASCENT-03 and TROPION-Breast02. Trop2 ADCs moving to the 1L setting in met TNBC not eligible for IO.
2
14
65